The efficacy and side effects of levetiracetam on refractory epilepsy in children

Journal of Pediatric Neurosciences

Volumn 7, Issue 1, 2012, Pages 19-22

  Incecik, Faruk ^a   Ozlem Herguner M ^a   Altunbasak, Sakir ^a  

^a CUKUROVA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Children; levetiracetam; refractory epilepsy; side effects

Indexed keywords

ETIRACETAM;

ADD ON THERAPY; ANOREXIA; ANTICONVULSANT THERAPY; ARTICLE; CHILD; DIZZINESS; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG TOLERABILITY; EPILEPSY; FATIGUE; FEMALE; FOCAL EPILEPSY; FOLLOW UP; GRAND MAL SEIZURE; HEADACHE; HUMAN; HYPERACTIVITY; IRRITABILITY; LENNOX GASTAUT SYNDROME; MAJOR CLINICAL STUDY; MALE; SEDATION; SEIZURE; SIDE EFFECT; SOMNOLENCE; TREATMENT OUTCOME;

EID: 84865597234     PISSN: 18171745     EISSN: 19983948     Source Type: Journal    
DOI: 10.4103/1817-1745.97614     Document Type: Article

References (16)

1. Grosso S, Cordelli DM, Franzoni E, Coppola G, Capovilla G, Zamponi N, et al. Efficacy and safety of levetiracetam in infants and young children with refractory epilepsy. Seizure 2007;16:345-50. (Pubitemid 46620674)
2. Coppola G, Mangano S, Tortorella G, Pelliccia A, Fels A, Romano A, et al. Levetiracetam during 1-year follow-up in children, adolescents, and young adults with refractory epilepsy. Epilepsy Res 2004;59:35-42. (Pubitemid 38595419)
3. Tonekaboni SH, Ghazavi M, Karimzadeh P, Mahvelati F, Ghofrani M. Efficacy of levetiracetam in children with refractory epilepsy as an add-on trial. Epilepsy Res 2010;90:273-7.
4. Tan MJ, Appleton RE. Efficacy and tolerability of levetiracetam in children aged 10 years and younger: a clinical experience. Seizure 2004;13:142-5. (Pubitemid 38404626)
5. Callenbach PM, Arts WF, ten Houten R, Augustijn P, Gunning WB, Peeters EA, et al. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study. Eur J Paediatr Neurol 2008;12:321-7. (Pubitemid 351689090)
6. Peake D, Mordekar S, Gosalakkal J, Mukhtyar B, Buch S, Crane J, et al. Retention rate of levetiracetam in children with intractable epilepsy at 1 year. Seizure 2007;16:185-9. (Pubitemid 46211180)
7. Nakken KO, Eriksson AS, Lossius RASM, Johannessen SI. A paradoxical effect of levetiracetam may be seen in both children and adults with refractory epilepsy. Seizure 2003;12:42-6. (Pubitemid 36113762)
8. Wheless JW, Ng YT. Levetiracetam in refractory pediatric epilepsy. J Child Neurol 2002;17:413-5. (Pubitemid 35012135)
9. Mandelbaum DE, Bunch M, Kugler SL, Venkatasubramanian A, Wollack JB. Efficacy of levetiracetam at 12 months in children classified by seizure type, cognitive status, and previous anticonvulsant drug use. J Child Neurol 2005;20:590-4. (Pubitemid 41245802)
10. Capovilla G, Beccaria F, Cagdas S, Montagnini A, Segala R, Paganelli D. Efficacy of levetiracetam in pharmacoresistant continuous spikes and waves during slow sleep. Acta Neurol Scand 2005;110:144-7.
11. Hoppen T, Sandrieser T, Rister M. Successful treatment of pharmacoresistent continuous spike wave activity during slow sleep with levetiracetam. Eur J Pediatr 2003;162:59-61. (Pubitemid 35478216)
12. De Los Reyes EC, Sharp GB, Williams JP, Hale SE. Levetiracetam in the treatment of Lennox-Gastaut syndrome. Pediatr Neurol 2004;30:254-6. (Pubitemid 38490436)
13. Koukkari MW, Guarino EJ. Retrospective study of the use of levetiracetam in childhood seizure disorders. J Child Neurol 2004;19:944-7. (Pubitemid 40214451)
14. French J, Edrich P, Cramer JA. A systematic review of the safety profile of levetiracetam: A new antiepileptic drug. Epilepsy Res 2001;47:77-90. (Pubitemid 32973650)
15. Li S, Cao J, Xiao N, Cai F. Efficacy and safety of levetiracetam as an addon therapy in children aged less than 4 years with refractory epilepsy. J Child Neurol 2010;25:609-13.
16. Thacker AK, Misra P, Gupta PP. Exacerbations of seizures by levetiracetam. Epilepsia 2008;49:177.